Cholangiocarcinoma risk factors and the potential role of aspirin

Hepatology. 2016 Sep;64(3):708-10. doi: 10.1002/hep.28613. Epub 2016 May 28.

Authors

Fabio Bagante^{1

2}, T Clark Gamblin³, Timothy M Pawlik¹

Affiliations

¹ Division of Surgical Oncology, Department of Surgery, Johns Hopkins Hospital, Baltimore, MD.
² Department of Surgery, University of Verona, Verona, Italy.
³ Department of Surgery, Medical College of Wisconsin, Milwaukee, WI.

PMID: 27112798
DOI: 10.1002/hep.28613

No abstract available

Publication types

Editorial
Comment

MeSH terms

Aspirin*
Bile Duct Neoplasms
Bile Ducts, Intrahepatic
Cholangiocarcinoma*
Humans
Risk Factors

Substances

Aspirin